Should I Get the SRT-100 for My Practice?
Superficial radiation therapy was first used to treat non-melanoma skin cancers, such as basal cell and squamous cell carcinomas, back in the 1970s. For the last few decades, the treatment method fell out of use due to a decline in available machinery. Now, the treatment is making a resurgence as our machine becomes more widespread. […]
The Best Keloid Scar Treatment Options
If you have keloid scars, chances are you’ve struggled with them for a while. These scars are notorious for their ability to resist attempts to treat or remove them, and often regrow a few years later. You have most likely asked yourself how to remove keloid scars a number of times. Here are a few […]
Medgadget Interview With CEO Joe Sardano
Sensus Healthcare’s FDA cleared low energy x-ray technology was the highlight of the discussion when Sensus Healthcare CEO, Joe Sardano, sat down with Medgadget’s Alice Ferng to discuss the benefits of using the SRT-100 and SRT-100 Vision. Click here to view the article.
Simple Daily Habits for Success – Inc.com
Looking to set yourself apart from the crowd in business or in life? Find out what Sensus Healthcare Co-Founder, Chairman and CEO, Joseph Sardano, has to say about it in Christina DesMarais’s article 24 Simple Daily Habits These High Achievers Swear by for Their Success on Inc.com. It’s that simple! “When you manage a results oriented […]
Sensus Healthcare Reports Third Quarter Financial Results Featuring Revenue up 44%
Marks eighth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 2, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the […]
Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
BOCA RATON, Fla., Nov. 1, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces it has launched the SRT-100™ in China for the treatment and prevention of keloids with Chindex Medical Limited. Sensus also announces the […]
